Table 2.
Lifestyle and Disease Characteristics Among Study Participants at the Diabetes Mellitus Clinic of MRRH Between July to October 2020
| Variable | Category | Frequency | Percentage (%) |
|---|---|---|---|
| Alcohol intake | Yes | 11 | 4.3 |
| No | 246 | 95.7 | |
| Physical exercise | Yes | 168 | 65.37 |
| No | 89 | 34.6 | |
| Smoking tobacco | Yes | 5 | 1.9 |
| No | 252 | 98.1 | |
| BMI | Normal | 99 | 38.5 |
| Overweight | 93 | 36.2 | |
| Obese | 65 | 25.3 | |
| Type of Diabetes | Type 1 | 4 | 1.6 |
| Type 2 | 253 | 98.4 | |
| Duration Diabetes | 5 Years and Below | 160 | 62.3 |
| Above 5 Years | 97 | 37.7 | |
| Presence of Comorbidity | Yes | 214 | 83.3 |
| No | 43 | 16.7 | |
| Type of Comorbidity | Hypertension | 143 | 66.8 |
| HIV | 52 | 24.3 | |
| Others | 19 | 18.4 | |
| Presence of Diabetes complication(s) | Yes | 148 | 81.3 |
| No | 109 | 18.7 | |
| Type of Diabetes Complication | Neuropathy | 119 | 79.9 |
| Retinopathy | 18 | 12.1 | |
| Others | 11 | 7.4 | |
| Antidiabetics used | Metformin | 35 | 13.6 |
| Insulin | 36 | 14.0 | |
| Glibenclamide | 1 | 0.4 | |
| Metformin and Insulin | 43 | 16.7 | |
| Metformin and Glibenclamide | 142 | 55.1 |